Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

High Yield of Active Tuberculosis Case Finding Among HIV-Infected Patients Using Xpert MTB/RIF Testing.

Kempker RR, Chkhartishvili N, Kinkladze I, Schechter MC, Harrington K, Rukhadze N, Dzigua L, Tserstvadze T, Del Rio C, Blumberg HM, Tukvadze N.

Open Forum Infect Dis. 2019 May 17;6(6):ofz233. doi: 10.1093/ofid/ofz233. eCollection 2019 Jun.

2.

Impact of hepatitis C virus recombinant form RF1_2k/1b on treatment outcomes within the Georgian national hepatitis C elimination program.

Karchava M, Chkhartishvili N, Sharvadze L, Abutidze A, Dvali N, Gatserelia L, Dzigua L, Bolokadze N, Dolmazashvili E, Kotorashvili A, Imnadze P, Gamkrelidze A, Tsertsvadze T.

Hepatol Res. 2018 Jan;48(1):36-44. doi: 10.1111/hepr.12890. Epub 2017 Apr 24.

PMID:
28258606
3.

The natural history of recent hepatitis C virus infection among blood donors and injection drug users in the country of Georgia.

Tsertsvadze T, Sharvadze L, Chkhartishvili N, Dzigua L, Karchava M, Gatserelia L, Abutidze A, Nelson KE.

Virol J. 2016 Feb 3;13:22. doi: 10.1186/s12985-016-0478-6.

4.

High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatment.

Karchava M, Waldenström J, Parker M, Hallack R, Sharvadze L, Gatserelia L, Chkhartishvili N, Dvali N, Dzigua L, Dolmazashvili E, Norder H, Tsertsvadze T.

Hepatol Res. 2015 Dec;45(13):1292-8. doi: 10.1111/hepr.12505. Epub 2015 Mar 24.

5.

Etiologic agents of central nervous system infections among febrile hospitalized patients in the country of Georgia.

Akhvlediani T, Bautista CT, Shakarishvili R, Tsertsvadze T, Imnadze P, Tatishvili N, Davitashvili T, Samkharadze T, Chlikadze R, Dvali N, Dzigua L, Karchava M, Gatserelia L, Macharashvili N, Kvirkvelia N, Habashy EE, Farrell M, Rowlinson E, Sejvar J, Hepburn M, Pimentel G, Dueger E, House B, Rivard R.

PLoS One. 2014 Nov 4;9(11):e111393. doi: 10.1371/journal.pone.0111393. eCollection 2014.

6.

IL28B favorable genotype and ultrarapid viral response as the earliest treatment predictors of a sustained viral response in a Georgian cohort infected with the hepatitis C genotype 1.

Karchava M, Sharvadze L, Chkhartishvili N, Nelson K, Gochitashivli N, Gatserelia L, Dvali N, Dolmazashvili E, Dzigua L, Badridze N, Zhamutashvili M, Tsertsvadze T.

Eur J Gastroenterol Hepatol. 2012 Jul;24(7):817-23. doi: 10.1097/MEG.0b013e328353fd11.

7.

Molecular detection of viral causes of encephalitis and meningitis in New York State.

Dupuis M, Hull R, Wang H, Nattanmai S, Glasheen B, Fusco H, Dzigua L, Markey K, Tavakoli NP.

J Med Virol. 2011 Dec;83(12):2172-81. doi: 10.1002/jmv.22169.

PMID:
22012726
8.

Expansion of CD3/CD16/CD56 positive NKT cells in HIV/AIDS: the pilot study.

Khvedelidze M, Chkhartishvili N, Abashidze L, Dzigua L, Tsertsvadze T.

Georgian Med News. 2008 Dec;(165):78-83.

PMID:
19124922
9.

Acute/recent HCV infection. Clinical course, viral replication kunetic and disease outcome.

Tsertsvadze T, Sharvadze L, Dzigua L, Dolmazashvili E, Nelson KE.

Georgian Med News. 2008 Dec;(165):43-9.

PMID:
19124916
10.

Detection and typing of human herpesvirus 6 by molecular methods in specimens from patients diagnosed with encephalitis or meningitis.

Tavakoli NP, Nattanmai S, Hull R, Fusco H, Dzigua L, Wang H, Dupuis M.

J Clin Microbiol. 2007 Dec;45(12):3972-8. Epub 2007 Oct 17.

Supplemental Content

Loading ...
Support Center